Answers are grounded in this paper and cite their sources.
Renal impairment was associated with reduced amantadine clearance. Based on pharmacokinetic modeling and simulations, dose regimens were recommended for subjects with impaired renal function to provide systemic amantadine exposure similar to subjects with normal renal function taking a once-daily extended-release amantadine tablet.
No takes yet. Share an insight, caveat, or question.
deVries et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: